2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Clinical trial NCT01353755 · COMPLETED

Trial details

NCT number: NCT01353755
Sponsor: Allergopharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinoconjunctivitis Allergic Asthma

Start date: 2009-10-01
Primary completion: 2012-08-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.